pancreatoduodenectomy pancreatoduodenectomy
Conditions
Interventions
For the intervention group, a combined test (RMiX) of the following i-iii will be performed
Tmm method: PCR of DNA from body fluids is performed to identify and quantify the initiating organisms by th
Sponsors
Fujii Tsutomu
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: Patients are scheduled to undergo pancreaticoduodenectomy. Patients must be at least 20 years of age at the time of enrollment. ECOG PS status 0, 1, or 2 The patient's consent to participate in this study was obtained.
Exclusion criteria
Exclusion criteria: History of serious drug hypersensitivity or drug allergy. Patients have obvious preoperative infection or inflammation (e.g., fever over 38.0 digree). Patient has a serious underlying disease (cardiac, pulmonary, metabolic, renal, cirrhosis, bowel obstruction, etc.) and is considered by the surgeon to be at high risk (more than 5%) of surgery-related mortality. Patients have dementia, psychosis, or psychiatric symptoms. Other conditions that make them unsuitable for the study as determined by the study investigator(s).
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| RMiX-PAT Treatment compliance rate | — |
Secondary
| Measure | Time frame |
|---|---|
| RMiX Target coverage | — |
Contacts
Public ContactHaruyoshi Tanaka
University of Toyama
Outcome results
None listed